بک لینک -

وان ایکس بت
سایت شرط بندی انفجار
سایت شرط بندی
سایت بازی انفجار
سایت enfejar
جت بت
سایت پیش بینی فوتبال
sibbet90
سایت بازی انفجار
پوکر آنلاین
بت بال 90
انفجار آنلاین
جت بت
بازی انفجار
سایت بازی انفجار

 درمان سرطان ریه درمان سرطان ریه .

درمان سرطان ریه

lung cancer treatment

There are two primary types of lung cancer, known as non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Named initially for how the cancer cells look under the microscope, these two account for 230,000 newly diagnosed cases of lung cancer in the U.S. each year.

The vast majority (85 percent) of lung cancers fall into the category called non-small cell lung cancer. Though this form of lung cancer progresses more slowly than SCLC, 40 percent of NSCLCs will have spread beyond the lungs by the time it is diagnosed.

“While many non-smokers can get lung cancer, the most prevalent risk factor for NSCLC is smoking,” explains Yale Medicine’s Roy S. Herbst, MD, PhD, Yale Cancer Center’s chief of medical oncology. 

Your overall exposure to smoking—the longer you smoke and the more packs you smoke in your lifetime—increases the risk for developing this type of cancer. Early detection offers the best prognosis for this type of lung cancer, because so many cases of NSCLC are not detected until they have spread (metastasized) to other areas of the body. Treatments for NSCLC include surgery, chemotherapy, radiation therapy and targeted therapy.

“The standard of care for lung cancer treatment has changed just in the last five years, due to advances in clinical research that our patients have contributed to,” says Anne Chiang, MD, PhD, a Yale Medicine medical oncologist who treats lung cancers. “There is real hope in the field that we are able to improve and extend patients’ lives.” 


برچسب: ،
ادامه مطلب
امتیاز دهید:
رتبه از پنج: 0
بازدید:

+ نوشته شده: ۱۳ آبان ۱۴۰۲ساعت: ۱۲:۳۷:۱۸ توسط:spudgene موضوع: نظرات (0)

Psilocybin

Are Shrooms Addictive?
Psychedelic mushrooms are not considered to be physically or psychologically addictive.12

However, mushrooms and other hallucinogens have a significant ability to cause tolerance, meaning that even occasional users may find that higher doses are necessary to get the same effect. This can increase the risk of negative effects and overdose given the unpredictably of the drug.12

Although the drug is not known to cause any withdrawal symptoms, users may still have a “come down” phase after using the drug that may include headaches, exhaustion, depression, and anxiety.2

Why Do People Use Shrooms?
In the past, hallucinogens were used for religious rituals to put people into a state of alternate reality, achieve visions, or make contact with spirits or a higher power. Most people today use them in social or recreational settings for fun, to relax, or to achieve a higher state of thinking or being.13

Psilocybin is found in mushrooms that are native to the tropical and subtropical areas of South America, Mexico, and the United States. Mushrooms containing these hallucinogens are consumed raw or dried or brewed into a tea.10

Many people who use shrooms abuse other drugs and alcohol. If you or someone you know needs help for a drug or alcohol problem, there are many treatment options available—both inpatient and outpatient. Desert Hope Treatment Centers offers a wide range of programs from medical detox to outpatient therapy.

It is never too late to get help for addiction.  rehab in Las Vegas, offers a comprehensive addiction treatment program.


برچسب: ،
ادامه مطلب
امتیاز دهید:
رتبه از پنج: 0
بازدید:

+ نوشته شده: ۱۳ آبان ۱۴۰۲ساعت: ۱۲:۳۵:۰۹ توسط:spudgene موضوع: نظرات (0)

PTSD Treatment

10 Ways to Help a Loved One With PTSD Treatment
If someone is concerned about a family member, friend, or relationship partner who struggles with PTSD, there are ways to demonstrate support, such as learning more about PTSD, offer assistance, and provide space.

Here are nine ways to provide support and encouragement to someone undergoing PTSD treatment:

Learn about the condition!
Take time to talk about their situation, or to simply listen
Provide personal space whenever needed
Offer assistance in scheduling or keeping therapy appointments<
Encourage healthy eating, sleep habits, and routine exercise
Consider attending one or more treatment sessions to learn how to be more helpful to their loved one
Plan activities with their loved one
Be a model of good self-care routines
Maintain healthy boundaries 
Equally important are the actions to avoid taking, as they can increase distress for your loved one. Things to avoid doing with someone who has PTSD include:

Avoid giving advice about their specific treatment plan. Leave that to the mental health professional
Don’t insist that they tell you about the trauma
If you are in a situation where your loved one is experiencing great distress and emergency services are needed, make sure you contact:

Suicide Prevention Lifeline at 1-800-273-8255.
9-1-1 for a life-threatening emergency
Final Thoughts
While coping with PTSD can be difficult, there are many types of therapeutic, psychopharmaceutical, and lifestyle interventions that can help manage PTSD symptoms in patients. Psychotherapy is typically the most recommended treatment, but remember that it can take some time to find the right fit, so do not be discouraged if the first few people are not the best match. Along with different forms of CBT-focused therapy, medications can also help manage the changes in brain chemistry associated with PTSD, thereby improving symptoms for patients. The effects of therapy and medication can be maximized further when combined with lifestyle changes, self-help interventions, and other techniques such as trauma-focused yoga. Managing PTSD can be difficult, but it is never too late to find the right treatment.


برچسب: ،
ادامه مطلب
امتیاز دهید:
رتبه از پنج: 0
بازدید:

+ نوشته شده: ۱۳ آبان ۱۴۰۲ساعت: ۱۲:۳۲:۰۴ توسط:spudgene موضوع: نظرات (0)

Microdosing Psilocybin

Researchers Test Microdosing Psilocybin on Rats to Create Treatment for Mental Disorders
 Psilocybin is defined as an active compound that can be found in mushrooms when using psychedelics. Researchers from the University of Southern Denmark conducted a study that provided new data on microdosing a small amount of psilocybin and its potential as a promising therapeutic treatment.

 

 The press release noted that psilocybin has been included in previous studies that assessed its use in depression and addiction using higher doses of therapy. Importantly, within these studies, participants undergo preparation before taking the dose. Prior to ingesting the psilocybin in a supportive and comfortable environment, the individual is monitored by a trained therapist as they enter the psychedelic experience.

However, researchers Mikael Palner, PhD, associate professor, and Kat Kiilerich, a PhD student from the University of Southern Denmark, have taken a different approach by using microdosing in rats. The pair observed the effects on rats when consuming a small dose of psilocybin—an even smaller dose than was administered in previous studies that also used microdosing.

“Microdosing is a phenomenon popularized within performance culture, notably in areas like Silicon Valley, California, and has subsequently spread through stories and anecdotes on the internet as a form of self-medication for various challenges,” Palner said in a press release.

The results proved that the low dose of repeated psilocybin was well tolerated in the rats and resulted in an increase in acceptability to stress and a decrease in compulsive behavior.

The researchers also found an increase of connection throughout of the thalamus section of the brain, which can filter decisions and concerns. The press release noted that this connection supported the positive effects of well-being individuals have reported when taking a small dose of mushrooms.

“The increased anxiety and stress in society currently have placed a strong focus on microdosing, leading to a surge in the trade of mushrooms. Countries such as the Netherlands, Australia, the USA, and Canada have either legalized or are in the process of legalizing psilocybin for therapeutic treatment,” Palner said in the press release. “It is, therefore, crucial that we understand the effects and side effects of these substances, which are already widely used by people around the world.”

The press release noted that with the current success of the repeated small dose in rats, researchers will soon be able to assess the effects on society.

The findings suggest that the use of psilocybin, repeated at a low dose, could offer a new form of treatment for individuals with differing forms of mental disorders.

 


برچسب: ،
ادامه مطلب
امتیاز دهید:
رتبه از پنج: 0
بازدید:

+ نوشته شده: ۱۳ آبان ۱۴۰۲ساعت: ۱۲:۳۰:۴۱ توسط:spudgene موضوع: نظرات (0)

Depression Treatment

Depression Treatment
 

How Do I Know if I Am Experiencing Depression?
The following questions may help you determine if you are experiencing depression.

During the past two weeks, how often have you been bothered by any of the problems listed below?

Little interest or pleasure in doing things?

Not at all.
Several days.
More than half the days.
Nearly every day.

Feeling down, depressed, or hopeless?

Not at all.
Several days.
More than half the days.
Nearly every day.

If you answered “more than half the days” or “nearly every day” to either question, you may be depressed and should seek help from your health care provider. Your provider can help figure out whether you have depression, and he or she can help find the best treatment for you. Depression can be treated with counseling, medications, or both.

If you think you may be depressed, the first step to seeking treatment is to talk to your health care provider. Remember that depression is not your fault. By asking for support, you are helping yourself and your family. Use a checklist to help you and your provider talk about your experiences.

Ways to begin the conversation include
“I read this information, and it sounds like how I feel. Can you help me find out if I have depression?”
“I don’t feel like myself. Could it be depression?”

In response, your health care provider should

Carefully review your completed checklist.
Ask several more questions about how you are feeling and acting.
Talk with you about treatment options.
Provide the name and number of a mental health specialist for you to visit. You can also visit CDC’s Resources to find help in your area.
After your visit, make sure to follow-up on all referrals and treatment that he or she suggests.

 


برچسب: ،
ادامه مطلب
امتیاز دهید:
رتبه از پنج: 0
بازدید:

+ نوشته شده: ۱۳ آبان ۱۴۰۲ساعت: ۱۲:۲۸:۳۴ توسط:spudgene موضوع: نظرات (0)

magic mushroom

WHAT IS PSILOCYBIN?
Nature is filled with extraordinary compounds. Plants produce all kinds of secondary alkaloids, often as a defense mechanism to protect themselves. Yet, scientists are still unsure of the purpose of one of Mother Nature’s most mysterious substances: psilocybin. Found in over 180 species of mushrooms in nearly every corner of the globe, psilocybin is a natural psychedelic alkaloid. In the body, it’s broken down into psilocin, which causes the psychedelic effects. There is a whole genus of mushrooms that contain psilocybin and psilocin: Psilocybe. There are also more psilocybin mushrooms outside of this genera, and some speculate there are even more to be discovered.

 

The most diverse species of psilocybin-containing mushrooms live in a magical country just south of the US, Mexico. The late Gastón Guzmán, who was a leading expert in Psilocybes and the first to discover many psilocybin species, estimated there were 55 different species in Mexico alone. However, his daughter, Laura Guzmán Dávalos, also an esteemed mycologist and professor at the University of Guadalajara in Jalisco, Mexico, tells me there may be even more species in less studied parts of the world, like Central and South America as well as Africa. In fact, she explains that although her father identified over 40 species in the Americas, she believes there are more to be found here, especially in remote, tropical jungles. It’s not that far-fetched of an idea considering that many mycologists like Dávalos believe only 3 to 8 percent of the estimated 2.2 to 3.5 million species of fungi have been named and identified at all.

With so many different species of psilocybin mushrooms, are there different magic mushroom experiences? Many psilonauts (those who regularly use magic mushrooms) would argue yes, and indigenous people who use mushrooms ceremonially would probably agree. The indigenous people of the Sierra Mazateca mountain region of Oaxaca, Mexico, believe different mushrooms have their own fuerza, or power. “There are certain species that are more prized and coveted,” Christopher Casuse, who has been working with the Mazatec for over a decade, tells me. For this reason, different species are employed for different ceremonial uses. Many mushroom users outside of the ceremonial context say something similar, that different types of mushrooms have their own “signature”; some create certain types of visual experiences, physical sensations, or have particularly strong introspective effects, for example.

This variance in experience could be due to the slightly different chemical structures of individual species and strains of shrooms. For instance, different species have varying levels of psilocybin and psilocin. And even among one species, strength varies. Psilocybe cubensis, one of the most popular species of psychedelic mushrooms, can have between 0.15 to 1.3 percent psilocybin and 0.11 to 0.5 percent psilocin. And it’s considered “moderately potent.” Plus, there can be many strains of one species of mushroom, especially among cubensis, which are also the most commonly cultivated psilocybin-containing mushrooms. What’s more, homegrown varieties can be stronger than naturally occurring strains due to advanced cultivation techniques.

But beyond psilocybin, there are even more secondary alkaloids produced by mushrooms that could be affecting the experience as well, such as baeocystin and norbaeocystin, though more research is needed to say for sure. It could be very similar to the “entourage effect” theory of the cannabis experience. While THC is the dominant alkaloid that produces the cannabis high, many scientists believe it’s actually the combined effect of the over 400 compounds found in the plant, including other cannabinoids and flavor-producing terpenes.

However, with psilocybin mushrooms, your environment and mind-set going into the experience may play an even larger role in their effect than the chemical composition of the fungi. A concept known as “set and setting” in the psychedelic community can drastically change the mushroom experience, often referred to as the “trip.” We’ll explore these ideas in more depth in later chapters, but they’re important concepts to get familiar with as we begin this journey.

Speaking of environment, Psilocybes grow in a wide variety of settings. While some prefer pastures and cow manure, others thrive on disturbed land in cloud forests. Paul Stamets, a leading authority on psilocybin mushrooms who’s identified a few new species, theorizes why they prefer such habitats in his book and identification guide, Psilocybin Mushrooms of the World. He writes that, before human civilization, psilocybin mushrooms thrived after ecological disasters like landslides, floods, hurricanes, and volcanoes. “This peculiar affection for disturbed habitats enables them to travel, following streams of debris.” Then when humans came into the picture, we were constantly creating ecological disturbances, and so we were the perfect creatures to coevolve with—always creating ideal conditions for shrooms to thrive. Now, psilocybin-containing mushrooms seem to grow at the edge of human civilization, near things like parking lots and graveyards, and they particularly love landscaped areas with mulch, like in front of police stations, causing Stamets to speculate “an innate intelligence on the part of the mushrooms.”


برچسب: ،
ادامه مطلب
امتیاز دهید:
رتبه از پنج: 0
بازدید:

+ نوشته شده: ۱۳ آبان ۱۴۰۲ساعت: ۱۲:۲۷:۰۹ توسط:spudgene موضوع: نظرات (0)

Half life of psilocybin

Psilocybin is a hallucinogenic compound found in about 200 mushroom species, including the liberty cap (Psilocybe semilanceata). For millennia, our ancestors have known and used this substance, and in recent years, it has received renewed interest from scientific researchers and therapists.

The substance has the potential to revolutionize the way we treat conditions such as severe depression and substance addiction, according to many. This is also the opinion of SDU researchers Himanshu Khandelia and Ali Asghar Hakami Zanjani from the Department of Physics, Chemistry and Pharmacy.

The two researchers have recently published the scientific paper The Molecular Basis of the Antidepressant Action of the Magic Mushroom extract, Psilocin. The article is the third in a series on the same topic from the two researchers (Interaction of psychedelic tryptamine derivatives with a lipid bilayer and Magic mushroom extracts in lipid membranes). The newest study's co-authors are Teresa Quynh Tram Nguyen and Luise Jacobsen. The work is supported by the Lundbeck Foundation and the Novo Nordisk Foundation.

Half life of psilocybin
"My interest was piqued when I heard a podcast about treating smoking addiction with psilocybin. And since psilocybin mushrooms grow everywhere in Denmark - I picked some in Svanninge Bakker - it wasn't difficult to start our research", said Himanshu Khandelia.
Together with Ali Asghar Hakami Zanjani, he is interested in understanding what happens at the molecular level when psilocybin enters the body, is converted to psilocin, and reaches the brain.

"Previous research has shown that psilocin binds to serotonin receptors in the brain. We show that psilocin binds stronger than serotonin to a 5-HT2AR serotonin receptor. This knowledge can be used if you want to design a drug that acts like psilocybin," explained Ali Asghar Hakami Zanjani.

Do not do this at home
Towards the end of the 1960s, many countries, especially the United States, tightened their legislation on psychoactive substances, and this also affected research on psilocybin and similar substances, which has been largely stagnant since the 1960s until a few years ago.

Today, countries like the United States, England, and Denmark are again active in the research field - now with a more cautious approach.

Hallucinations and the feeling of being disconnected from the world will come along whether one eats a psilocybin mushroom to take a trip or one takes the substance in a medically prescribed tablet, and this calls for caution, explains Ali Asghar Hakami Zanjani:

"Research shows that you experience something different. It is a form of hallucination. The characteristic is that patients may get a whole new perspective on their situation: for example, a terminally ill cancer patient may lose their fear of dying soon and instead experience acceptance of their life situation. Such sessions should take place in safe and guiding settings led by trained therapists. Today, no one would recommend just eating some mushrooms at home in their own living room".


برچسب: ،
ادامه مطلب
امتیاز دهید:
رتبه از پنج: 0
بازدید:

+ نوشته شده: ۱۳ آبان ۱۴۰۲ساعت: ۱۲:۲۶:۰۷ توسط:spudgene موضوع: نظرات (0)

Depression Treatment

Depression Symptoms and Treatment

The MEPS used the Patient Health Questionnaire-2 (PHQ-2), a brief screen for depressed mood and anhedonia during the past 2 weeks, to screen for depression. A PHQ-2 score of 3 or more (scores range from 0 to 6, with higher scores indicating more severe depressive symptoms) defined screen-positive depression. In primary care patients, a PHQ-2 score of 3 or more has a sensitivity of 0.61 to 0.87 and specificity of 0.78 to 0.92 for major depressive disorder which refers to more severe rather than mild depression.19-21 In a validation study of 88 primary care patients with a PHQ-2 score of 3 or more, 34 (38.6%) had major depressive disorder, 32 (36.3%) had other less severe depression, and 22 (25.0%) had neither type of depression.19

Detailed data were collected directly from households using 3 interviews during each survey year. Treatment of depression was defined by an outpatient visit or use of antidepressant, antipsychotic, mood stabilizer, or anxiolytic medications, or psychotherapy for depression (International Classification of Diseases, 9th Revision, codes 296.2, 296.3, 300.4, and 311) without regard to clinical effectiveness. Patients treated for bipolar disorder were excluded from the definition of depression treatment.

Respondents indicated whether each visit included psychotherapy or mental health counseling. One or more psychotherapy or counseling visits defined use of psychotherapy. Three groups were defined: any psychotherapy, any antidepressant treatment, and combination treatment. Information was also collected concerning the health care professionals providing treatment at each visit. Respondents were classified into those who received depression treatment from (1) any psychiatrist, (2) any social worker or psychologist, and (3) only general medical professionals (ie, health care professionals other than psychiatrists, psychologists, or social workers). The 2 mental health specialty groups were not mutually exclusive.

 


برچسب: ،
ادامه مطلب
امتیاز دهید:
رتبه از پنج: 0
بازدید:

+ نوشته شده: ۹ آبان ۱۴۰۲ساعت: ۰۳:۱۶:۳۵ توسط:spudgene موضوع: نظرات (0)

microdosing psilocybin

Microdosing psychedelics may offer unique health benefits, according to a growing body of research.
A new study found that people who reported microdosing psilocybin saw improvements in symptoms of depression, anxiety, and stress compared to people who did not microdose psychedelics.
Psychedelic research is expanding and the results seem promising, but more rigorous studies are needed to determine whether psychedelic microdosing may be effective for treating mental health conditions.
Repeated use of small quantities of the psychedelic substance psilocybin can improve mood and mental health, a new study suggests.

Researchers found that people who microdosed psilocybin saw “small- to medium-sized” improvements in symptoms of depression, anxiety, and stress over a 30-day follow-up, compared to those who did not.

This observational study, published June 30 in Nature-Scientific ReportsTrusted Source, included over 900 people who reported microdosing psilocybin during the past month, and a control group of 180 people who did not engage in microdosing psychedelics.

“This is the largest longitudinal study of this kind to date of microdosing psilocybin and one of the few studies to engage a control group,” study author Zach Walsh, PhD, a professor of psychology at the University of British Columbia Okanagan Campus in Kelowna, said in a press release.

“[The results] add to the growing conversation about the therapeutic potential of microdosing,” he added.

Mental health benefits of microdosing

When it comes to psychedelics, microdosing involves consuming psychedelic substances in amounts too small to impair daily functioning. The doغیر مجاز می باشدe may vary but could be taken 3 to 5 times per week.

The 2021 Global Drug Survey (GDS) found that 1 in 4 people who used psychedelics reported microdosing psilocybin mushrooms or LSD in the past 12 months. These two substances are the most widely used for microdosing, but the survey also found that about one-third of people who used psychedelics microdosed another psychedelic substance.

Although most people have a sense of a microdose as being very small, Dustin Hines, PhD, an assistant professor of neuroscience in the department of psychology at the University of Nevada, Las Vegas, said one challenge for this kind of research is accurately defining the size of that dose.

“In establishing a microdose, people are looking to have normal cognitive functioning — they can still carry out their work duties or other responsibilities without noticing a negative impact,” he said, adding that the appropriate microdose may vary from person to person and situation to situation.

In the new study, participants reported on their recent use of microdosing psychedelic mushrooms and completed a number of assessments on their mood and mental health, noting a number of improvements.


برچسب: ،
ادامه مطلب
امتیاز دهید:
رتبه از پنج: 0
بازدید:

+ نوشته شده: ۹ آبان ۱۴۰۲ساعت: ۰۳:۱۲:۵۶ توسط:spudgene موضوع: نظرات (0)

PTSD

PTSD Treatment

Learn more about PTSD treatment at Options Behavioral Health System in Indianapolis, IN

Experiencing a traumatic event can cause a great deal of pain. For some individuals that have experienced a traumatic event, over time, the associated fear and anxiety eventually dissipate. For others, however, the fear and anxiety remain constant, or even worsen, as time passes. In such instances, it is possible that these individuals are suffering from posttraumatic stress disorder, or PTSD.

Posttraumatic stress disorder is a mental illness that is caused by being exposed to a traumatic event. A traumatic event can be anything that invokes feelings of helplessness and fear, or that may cause an individual to believe that his or her life, or the life of a loved one, is in danger. Examples of traumatic events include domestic violence, car accidents, natural disasters, rape, and military combat.

At Options Behavioral Health, we understand the complexities of PTSD and the degree of anguish that this disorder can cause. We also know that facing the emotions that result from experiencing a traumatic event may seem unbearable. However, we are proud to have helped many people at our center learn to manage the symptoms of PTSD by offering state-of-the-art treatment that is provided by an experienced team of professionals. Options Behavioral Health is an 84-bed, free-standing psychiatric hospital devoted to providing a full continuum of care for adolescents, ages 12 to 18, adults, and older adults who are battling the symptoms of any number of mental health concerns, including posttraumatic stress disorder. At our hospital, individuals can learn the tools they need to successfully achieve a brighter future.

 


برچسب: ،
ادامه مطلب
امتیاز دهید:
رتبه از پنج: 0
بازدید:

+ نوشته شده: ۹ آبان ۱۴۰۲ساعت: ۰۳:۰۸:۱۹ توسط:spudgene موضوع: نظرات (0)